The weekend breakthrough in trade talks between the EU and US provided a fillip to markets early in the trading week, but the details of the agreement are scant, and key areas are yet to be determined - notably pharmaceuticals.
A baseline 15% tariff has been agreed on EU exports to the US, with no additional tariffs from the EU on US products.
There are conflicting media reports on pharmaceuticals, with some suggesting 15% would apply immediately, while others suggest a carve out below that rate for some areas.